The FDA approved milnacipran (Savella) for fibromyalgia pain treatment on January 14, 2009. Milnacipran is a selective norepinephrine and serotonin reuptake inhibitor.
The drug was originally developed and manufactured by Pierre Fabre Medicament in France. It was approved in that country as an antidepressant in 1997. Cypress Bioscience and Forest Laboratories partnered with Pierre [...]
A recent study led by Rahul Khare, MD, emergency department physician and assistant director of operations at Northwestern Memorial Hospital, sought to determine the cost-effectiveness of utilizing a CT scanner to evaluate low-risk chest pain patients in the emergency room. The study results which are published in the July issue of Academic Emergency Medicine show [...]
The first-ever functional brain imaging study of chronic pain conducted in children, done by researchers at Harvard-affiliated McLean Hospital and Children’s Hospital Boston, has shed new light on a mysterious condition known as complex regional pain syndrome (CRPS) and offers hope for a better understanding of the disorder in both children and adults. The study, [...]
The first-ever functional brain imaging study of chronic pain conducted in children, done by researchers at Harvard-affiliated McLean Hospital and Children’s Hospital Boston, has shed new light on a mysterious condition known as complex regional pain syndrome (CRPS) and offers hope for a better understanding of the disorder in both children and adults. The study, [...]
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), announces awards to eight academic research centers to conduct collaborative studies of urologic chronic pelvic pain disorders by looking for clues outside the bladder and prostate. The total research investment for the five-year project is estimated [...]
A new type of drug could alleviate pain in a similar way to cannabis without affecting the brain, according to a new study published in the journal Pain on Monday 15 September.
The research demonstrates for the first time that cannabinoid receptors called CB2, which can be activated by cannabis use, are present in human sensory [...]
According to the American Pain Foundation, some 76.2 million people, or 26 percent of the population, suffer from pain that lasts more than 24 hours.
For most people, the pain will eventually subside or even disappear; however, for 42 percent of those with pain, it will last longer than a year. In order to get effective [...]
This week, University of Michigan scientists will begin a phase 1 clinical trial for the treatment of cancer-related pain, using a novel gene transfer vector injected into the skin to deliver a pain-relieving gene to the nervous system.
A gene transfer vector is an agent used to carry genes into cells. In this groundbreaking clinical trial, [...]
Misconceptions about chronic pain can do harm to people with legitimate medical problems. Patients with chronic pain can and should be treated. Dispelling these damaging myths should raise awareness and encourage more people to seek help with a professional trained in treating chronic pain.
Chronic pain is defined as pain that persists for at least 6 [...]
Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the U.K.’s National Institute for Health and Clinical Excellence (NICE) recommending the use of spinal cord stimulation (SCS) for patients with chronic neuropathic pain. In its comprehensive final guidance, NICE confirmed that SCS is both safe and clinically effective in these patients. Importantly, NICE also [...]